CardioVascular BioTherapeutics
CardioVascular BioTherapeutics is a development stage biopharmaceutical company advancing biologic drug candidates to address diseases such as diabetic wounds, severe ischemic heart disease, peripheral artery disease, erectile dysfunction, and infarct stroke. CVBT is focused on research & development aimed at improving the quality of life for those suffering from ischemic tissue and organs.
Industries
biotechnology
medical
pharmaceutical
Nr. of Employees
small (1-50)